The Study of Chinese Medicine for the Treatment of Primary Osteoporosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to evaluate the efficacy and possible mechanism of traditional Chinese medicine in the treatment of primary osteoporosis (Kidney Yang Deficiency Syndrome).It is a randomized, placebo-controlled trial.
Epistemonikos ID: 55ae0fffe35d6861817ec60fe3ee4b27bf0a0786
First added on: May 13, 2024